TGTX
NASDAQ
US
TG Therapeutics, Inc. - Common Stock
$33,53
▼ $-0,05
(-0,15%)
Vol. 1.5M
11
Punteggio di Qualità
ok
Analisi approfondita
2/5
ok
Ricavi ✓
Utile netto ✓
>IPO ✗
Cap. mercato
$4.7B
P/E
10,6
ROE
133,3%
Margine
84,1%
D/E
40,36
Beta
1,84
52W
$25–$46
Consenso Wall Street
15 analisti · Apr 20263
Acquisto forte
9
Compra
2
Mantieni
1
Vendi
0
Vendita forte
80,0%
Rating Compra
Grafico dei Prezzi
Titoli simili
MIRM
Mirum Pharmaceuticals Inc
$4.1B
PTCT
PTC Therapeutics Inc
P/E 8,1
$6.1B
ERAS
Erasca Inc
$1.1B
CAI
Caris Life Sciences Inc
$7.6B
CELC
Celcuity Inc
$4.6B
APLS
Apellis Pharmaceuticals Inc
P/E 70,7
$3.2B
IMVT
Immunovant Inc
$5.1B
APGE
Apogee Therapeutics Inc
$5.2B
DNTH
Dianthus Therapeutics Inc
$1.8B
FOLD
Amicus Therapeutics Inc
$4.4B
Utili
Tasso di battuta: 0,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $0,36 | $0,14 | $-0,22 |
| Set 2025 | $0,22 | $0,16 | $-0,06 |
| Giu 2025 | $0,22 | $0,17 | $-0,05 |
| Mar 2025 | $0,19 | $0,03 | $-0,16 |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 26.0% | 26.1% | 26.1% | 26.1% | 133.2% | 133.3% |
| P/E (TTM) | 94.80 | 73.27 | 94.81 | 91.28 | 10.87 | 10.58 |
| Net Margin | 19.8% | 13.3% | 13.3% | 13.3% | 84.1% | 84.1% |
| Gross Margin | 86.6% | 87.0% | 87.0% | 87.0% | 85.3% | 85.3% |
| D/E Ratio | 88.77 | 88.64 | 88.64 | 88.64 | 40.40 | 40.36 |
| Current Ratio | 3.86 | 3.86 | 3.86 | 3.86 | 3.82 | 3.82 |
Rapporti chiave
ROA (TTM)
60,4%
P/S (TTM)
8,90
P/B
21,1
EPS (TTM)
$2,78
CF/Share
$-0,18
Crescita ricavi 3A
+266,4%
52W High
$46,48
52W Low
$25,28
$25,28
Intervallo 52 settimane
$46,48
Як TGTX виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка TGTX vs аналоги Biotechnology
P/E
10,6
▼
44%
sotto
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
8,9
▼
31%
sotto
peer
(12,9)
vs Peer
vs Settore
Più costoso
P/B
21,1
▲
757%
sopra
peer
(2,5)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість TGTX vs аналоги Biotechnology
ROE
133,3%
▲
298%
sopra
peer
(-67,3%)
vs Peer
vs Settore
Top livello
Net margin
84,1%
▲
129%
sopra
peer
(-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
85,3%
▲
9%
sopra
peer
(78,6%)
vs Peer
vs Settore
Debole
ROA
60,4%
▲
229%
sopra
peer
(-46,7%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя TGTX vs аналоги Biotechnology
D/E ratio
40,4
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
3,8
▼
14%
sotto
peer
(4,4)
vs Peer
vs Settore
In linea
Beta
1,8
▲
89%
sopra
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів TGTX
TGTX
Mediana peer
Industria
TGTX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio